JP2024543125A5 - - Google Patents
Info
- Publication number
- JP2024543125A5 JP2024543125A5 JP2024530529A JP2024530529A JP2024543125A5 JP 2024543125 A5 JP2024543125 A5 JP 2024543125A5 JP 2024530529 A JP2024530529 A JP 2024530529A JP 2024530529 A JP2024530529 A JP 2024530529A JP 2024543125 A5 JP2024543125 A5 JP 2024543125A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- composition
- biopharmaceutical
- pharmaceutically acceptable
- biopharmaceutical compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2117005.5A GB202117005D0 (en) | 2021-11-25 | 2021-11-25 | New pharmaceutical composition |
| GB2117005.5 | 2021-11-25 | ||
| GB2208144.2 | 2022-06-01 | ||
| GBGB2208144.2A GB202208144D0 (en) | 2022-06-01 | 2022-06-01 | New pharmaceutical composition |
| GBGB2213306.0A GB202213306D0 (en) | 2022-09-12 | 2022-09-12 | New pharmaceutical composition |
| GB2213306.0 | 2022-09-12 | ||
| PCT/GB2022/052985 WO2023094818A1 (en) | 2021-11-25 | 2022-11-25 | Pharmaceutical composition comprising biopharmaceutical drug compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024543125A JP2024543125A (ja) | 2024-11-19 |
| JP2024543125A5 true JP2024543125A5 (cg-RX-API-DMAC10.html) | 2025-12-02 |
Family
ID=84367624
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024530529A Pending JP2024543125A (ja) | 2021-11-25 | 2022-11-25 | バイオ医薬品化合物を含む医薬組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240408212A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4436551A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024543125A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20240111761A (cg-RX-API-DMAC10.html) |
| AR (1) | AR127783A1 (cg-RX-API-DMAC10.html) |
| AU (1) | AU2022398370A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3239053A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL313015A (cg-RX-API-DMAC10.html) |
| MX (1) | MX2024006130A (cg-RX-API-DMAC10.html) |
| TW (1) | TW202329916A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023094818A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12414916B2 (en) | 2021-06-10 | 2025-09-16 | Belhaven BioPharma Inc. | Dry powder formulations of epinephrine and associated methods |
| US12661315B2 (en) | 2021-06-10 | 2026-06-23 | Belhaven BioPharma Inc. | Dry powder formulations of epinephrine and associated methods |
| CN118461230B (zh) * | 2024-05-15 | 2026-07-10 | 中山大学 | 一种植物多糖纳米纤维膜及其制备方法和应用 |
| US20260108465A1 (en) | 2024-10-21 | 2026-04-23 | Belhaven BioPharma Inc. | Compositions, devices, and methods for intranasal delivery of dry powder epinephrine |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19518810A1 (de) | 1995-05-26 | 1996-11-28 | Bayer Ag | Nasal-Applikator |
| DE69913113T2 (de) | 1998-03-10 | 2004-08-26 | Valois S.A.S. | Behälter, verfahren zur befüllung dieses behälter und abgabevorrichtung für das im behälter enthaltene pulver |
| FR2817847B1 (fr) | 2000-12-08 | 2003-03-28 | Tebro | Dispositif de distribution de produit fluide ou pulverulent |
| LU90825B1 (en) | 2001-09-06 | 2003-03-07 | Iee Sarl | Method for the determination of one or more parameters of a seat passenger |
| CA2540204A1 (en) | 2003-10-09 | 2005-04-21 | Bioactis Limited | Device to deliver powdery medicine into nasal cavity |
| EP1834651A1 (en) * | 2006-03-15 | 2007-09-19 | Universiteit Gent | Compositions and methods for veterinary vaccination |
| SG2013054218A (en) * | 2008-01-15 | 2014-10-30 | Abbott Gmbh & Co Kg | Powdered protein compositions and methods of making same |
| EP2266563A1 (en) | 2009-06-11 | 2010-12-29 | Charité-Universitätsmedizin Berlin (Charité) | Use of opioid receptor antagonists for acute treatment of paraphilic arousal states |
| US8827946B2 (en) | 2009-07-31 | 2014-09-09 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal granisetron and nasal applicator |
| JP5623355B2 (ja) | 2010-07-30 | 2014-11-12 | オートリブ ディベロップメント エービー | カーテンエアバッグ |
| CN104470569B (zh) | 2012-06-28 | 2018-04-27 | 美国政府(由卫生和人类服务部的部长所代表) | 用于疫苗和其它治疗试剂的鼻干粉递送系统 |
| FR3007992B1 (fr) | 2013-07-05 | 2018-01-26 | Aptar France Sas | Dispositif de distribution de produit fluide ou pulverulent. |
| JP6611720B2 (ja) * | 2013-09-03 | 2019-11-27 | ジョージア テック リサーチ コーポレイション | 熱安定性ワクチン製剤及びマイクロニードル |
| CN104489669A (zh) * | 2014-12-12 | 2015-04-08 | 深圳先进技术研究院 | 一种植物酵素益生菌粉及其制备方法 |
| CN110996912A (zh) | 2017-08-20 | 2020-04-10 | 福摩莱克斯医药创新有限公司 | 用于鼻内递送的干粉组合物 |
| EP3698773A1 (en) * | 2019-02-21 | 2020-08-26 | Università degli Studi di Parma | Composition and manufacturing of powders containing nanoadjuvants for mucosal vaccination |
| US10653690B1 (en) * | 2019-07-09 | 2020-05-19 | Orexo Ab | Pharmaceutical composition for nasal delivery |
| FR3098420B1 (fr) | 2019-07-10 | 2021-07-09 | Aptar France Sas | Dispositif de distribution nasale de poudre |
| CN121265577A (zh) * | 2020-05-18 | 2026-01-06 | 奥瑞克索股份公司 | 用于药物递送的药物组合物 |
| FR3121047B1 (fr) | 2021-03-29 | 2023-07-14 | Aptar France Sas | Dispositif de distribution nasale de poudre |
-
2022
- 2022-11-25 IL IL313015A patent/IL313015A/en unknown
- 2022-11-25 TW TW111145223A patent/TW202329916A/zh unknown
- 2022-11-25 AU AU2022398370A patent/AU2022398370A1/en active Pending
- 2022-11-25 KR KR1020247018845A patent/KR20240111761A/ko active Pending
- 2022-11-25 JP JP2024530529A patent/JP2024543125A/ja active Pending
- 2022-11-25 US US18/712,027 patent/US20240408212A1/en active Pending
- 2022-11-25 MX MX2024006130A patent/MX2024006130A/es unknown
- 2022-11-25 CA CA3239053A patent/CA3239053A1/en active Pending
- 2022-11-25 AR ARP220103247A patent/AR127783A1/es unknown
- 2022-11-25 EP EP22814493.7A patent/EP4436551A1/en active Pending
- 2022-11-25 WO PCT/GB2022/052985 patent/WO2023094818A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022540227A5 (cg-RX-API-DMAC10.html) | ||
| JP2024541470A5 (cg-RX-API-DMAC10.html) | ||
| CN102149368B (zh) | 治疗剂通过粘膜或皮肤吸收的改善 | |
| CN102686218B (zh) | 含纳米微粒的口服固体剂型和使用鱼胶配制所述剂型的方法 | |
| MD3962455T2 (ro) | Compoziție farmaceutică nouă pentru livrare de medicamente | |
| KR101763195B1 (ko) | 건조 분말 반코마이신 조성물 및 관련 방법 | |
| ES2953878T3 (es) | Composición que comprende al menos dos polvos secos obtenidos mediante secado por aspersión para aumentar la estabilidad de la formulación | |
| TW201113259A (en) | Diketopiperazine microparticles with defined isomer contents | |
| JP2020511522A (ja) | グルコキナーゼ活性化剤の経口製剤およびその製造方法 | |
| BR122019026637B1 (pt) | Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco | |
| KR20070111497A (ko) | 약의 경점막 투여에 유용한 새로운 약학 조성물 | |
| JP2011052021A (ja) | 鼻腔送達用医薬品組成物 | |
| WO1993025193A1 (fr) | Preparation pharmaceutique destinee a etre administree par les voies respiratoires | |
| US8226982B2 (en) | Inhalable powders comprising protein, phenylalanine, and other protein stabilizers | |
| TW202333658A (zh) | 包含腎上腺素之新穎醫藥組合物 | |
| JP2024542520A5 (cg-RX-API-DMAC10.html) | ||
| KR20240111769A (ko) | 비강내 투여에 사용되는 새로운 약학적 장치 | |
| TW202329916A (zh) | 包含生物醫藥藥物化合物之新穎醫藥組合物 | |
| ES2357607T3 (es) | Composiciones intranasales. | |
| WO2002015876A2 (en) | Amorphous carrier materials for drug delivery | |
| EP1829549A1 (en) | Amorphous composition | |
| GB2395900A (en) | Therapeutic composition for respiratory delivery | |
| CN1682883A (zh) | 肿节风固体分散体及其制备方法 | |
| JP2023526098A5 (cg-RX-API-DMAC10.html) | ||
| CN117298089A (zh) | 磷酸奥司他韦口服组合物 |